Director's Dealing • Sep 8, 2020
Director's Dealing
Open in ViewerOpens in native device viewer
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes reports the following transactions under ISIN DK0060336014, Novozymes B shares under the symbol NZYM B.
| Details of the person discharging managerial responsibilities/person closely associated | ||
|---|---|---|
| Name | Claus Crone Fuglsang | +45 3077 8682 |
| Reason for notification | Carl Ahlgren | |
| Position/status | CSO and Executive Vice President, Research & Development | +45 3077 2783 |
| Initial notification/ amendment |
Initial notification | Ulrik Wu Svare |
| Details of the issuer | +45 3077 3187 |
| Entity | Novozymes A/S | ||
|---|---|---|---|
| LEI code | 529900T6WNZXD2R3JW38 |
| Description: | |||
|---|---|---|---|
| Financial instrument | Shares | ||
| Identification code | ISIN DK0060336014 | ||
| Nature of the transaction | Purchase of shares from exercise of stock options | ||
| Place(s) of transaction(s), price(s) and volume(s) |
Place(s) Novozymes' custody account Novozymes' custody account |
Price(s) 300.90 273.60 |
Volume(s) 7,311 shares 7,632 shares |
| Aggregated information | Number of shares: 14,943 Average price, DKK: 287,00 Transaction value, DKK: 4,287,995.10 |
||
| Date of the transaction | 2020-08-09 09:24 CEST |
Contact information [email protected]
Tobias Cornelius Björklund [email protected]
Novozymes is the world leader in biological solutions. Together with customers, partners and the global community, we improve industrial performance while preserving the planet's resources and helping build better lives. As the world's largest provider of enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energyefficient production, renewable fuel and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. www.novozymes.com
Novozymes A/S CVR number: 10 00 71 27 LEI: 529900T6WNZXD2R3JW38
Novozymes A/S Krogshoejvej 36 2880 Bagsvaerd Denmark
Phone: +45 4446 0000
Name Claus Crone Fuglsang
| Position/status | CSO and Executive Vice President, Research & Development |
|---|---|
| Initial notification/ | Initial notification |
| amendment |
| Entity | Novozymes A/S |
|---|---|
| LEI code | 529900T6WNZXD2R3JW38 |
| Description: | ||||
|---|---|---|---|---|
| Financial instrument | Shares | |||
| Identification code | ISIN DK0060336014 | |||
| Nature of the transaction | Shares sold | |||
| Place(s) of transaction(s), | ||||
| price(s) and volume(s) | Place(s) | Price(s) | Volume(s) | |
| See appendix | See appendix | 11,264 shares | ||
| Aggregated information | Number of shares: 11,264 | |||
| Average price, DKK: 384.65 | ||||
| Transaction value, DKK: 4,332,684.09 | ||||
| Date of the transaction | 2020-08-09 |
| Date & Time | Volume | Price | Venue |
|---|---|---|---|
| 09-08-20 09:24:44 | 3,532 | 384.65 | XCSE |
| 09-08-20 09:24:44 | 1,964 | 384.65 | XCSE |
| 09-08-20 09:24:44 | 971 | 384.65 | XCSE |
| 09-08-20 09:24:44 | 2,724 | 384.65 | XCSE |
| 09-08-20 09:24:44 | 1,250 | 384.65 | XCSE |
| 09-08-20 09:24:44 | 733 | 384.65 | XCSE |
| 09-08-20 09:24:45 | 90 | 384.50 | XCSE |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.